前列腺炎症:良性前列腺梗阻所致男性下尿路症状的潜在治疗靶点
本文为叙述性综述,评估前列腺炎症作为良性前列腺梗阻所致男性下尿路症状治疗靶点的作用,并汇总现有抗炎机制治疗。综述分析了磷酸二酯酶5抑制剂、非甾体抗炎药、维生素D3受体类似物、植物疗法、他汀及生活方式改变,临床前证据显示这些治疗对前列腺有抗炎作用,但各疗法成熟度差异大,研究设计、患者数和随访时长差异显著,需进一步高质量长期研究。
要点
- 前列腺炎症是BPO相关LUTS的潜在治疗靶点,但现有抗炎疗法证据成熟度不一。
- 已综述的抗炎机制疗法包括PDE5抑制剂、NSAIDs、维生素D3受体类似物、植物疗法、他汀和生活方式改变。
- 需进一步高质量长期研究以明确新药在日常实践中的定位。
核心结论
- 多种药物类别已被研究对前列腺炎症及男性LUTS改善的影响,数据支持使用可能改变和改善前列腺炎症环境的药物,但需进一步高质量长期研究确定新药在日常实践中的确切定位。
研究设计与样本
- 叙述性综述,对已确立和研究性抗炎机制治疗用于男性BPO所致LUTS的研究进行了广泛文献检索。
主要发现
- 临床前证据显示磷酸二酯酶5抑制剂、非甾体抗炎药、维生素D3受体类似物、植物疗法、他汀及生活方式改变对前列腺有抗炎作用。
- 各疗法成熟度差异大,且研究在设计、患者数量和随访时长方面存在显著差异。
临床怎么用
- 综述数据支持对BPO所致LUTS男性使用可能改变和改善前列腺炎症环境的药物,但新药在日常实践中的确切定位需进一步高质量长期研究。
局限性
- 各疗法研究在设计、患者数量和随访时长方面存在显著差异,且各疗法成熟度差异大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this narrative review is to evaluate the role of prostatic inflammation as a treatment target for lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO) and provide an update on the available therapies. METHODS: An extensive literature search was conducted for studies on established and investigational treatments with anti-inflammatory mechanism of action that has been assessed for the management of male LUTS due to BPO. RESULTS: Data on phosphodiesterase 5 inhibitors, nonsteroidal anti-inflammatory drugs, vitamin D3 receptor analogs, phytotherapy, statins, and lifestyle changes have been reviewed and analyzed. Preclinical evidence has shown the anti-inflammatory effect of these treatments on prostate. However, there is a wide variation in the degree of mature of each therapy. In addition, there are significant differences between the studies in terms of design, number of patients, and duration of follow-up. CONCLUSIONS: Several drugs classes have been investigated for their impact on prostatic inflammation and improvement of male LUTS. The reviewed data support the rationale for use of agents that may alter and improve the inflammatory environment in the prostate in men with LUTS, but further high-quality long-term studies are required for the exact positioning of the new drugs in daily practice.
引用
- Samarinas M, Gacci M, de la Taille A, et al. Prostatic inflammation: a potential treatment target for male LUTS due to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2018. PMID: 29686417. doi:10.1038/s41391-018-0039-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。